Indegene Ltd

Indegene Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Indegene Ltd

₹ 578 2.06%
28 Mar - close price
indegene.com BSE: 544172 NSE: INDGN
About

Incorporated in 1998, Indegene Ltd provides
solutions consisting of analytics, technology
and commercial, medical, regulatory and
safety services to life science and health
care organizations[1]

Key Points

Business Overview:[1]
IL is a digital-first healthcare and technology company. It helps bio pharmaceutical, emerging biotech and medical device companies to develop products and get them to market. Company brings together healthcare domain expertise, technology and an agile operating model to provide diverse solutions for patients and physicians.

Website BSE NSE
  • Market Cap ₹ 13,881 Cr.
  • Current Price ₹ 578
  • High / Low ₹ 737 / 469
  • Stock P/E 36.3
  • Book Value ₹ 98.5
  • Dividend Yield 0.00 %
  • ROCE 29.0 %
  • ROE 26.9 %
  • Face Value ₹ 2.00
    Edit ratios

    Pros

    • Company has reduced debt.
    • Company is almost debt free.
    • Company has delivered good profit growth of 88.5% CAGR over last 5 years
    • Company has a good return on equity (ROE) track record: 3 Years ROE 29.2%

    Cons

    • Though the company is reporting repeated profits, it is not paying out dividend

    * The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

    Peer comparison

    Sector: Healthcare Industry: Miscellaneous

    Part of BSE Allcap BSE IPO Nifty MidSmallcap 400 BSE Healthcare Nifty Smallcap 250

    Edit Columns
    Loading peers table ...

      Quarterly Results

      Consolidated Figures in Rs. Crores / View Standalone

      Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024
      632 608 636 673 673 676 687 720
      535 511 515 524 534 548 561 589
      Operating Profit 97 97 121 149 139 129 126 132
      OPM % 15% 16% 19% 22% 21% 19% 18% 18%
      13 28 12 13 26 22 21 38
      Interest 12 13 12 12 12 12 4 3
      Depreciation 20 20 20 18 18 20 19 20
      Profit before tax 79 92 101 132 134 120 124 146
      Tax % 38% 26% 25% 25% 29% 27% 26% 25%
      49 68 75 99 95 88 92 110
      EPS in Rs 2.20 3.08 3.38 4.45 4.26 3.67 3.83 4.58
      Raw PDF

      Profit & Loss

      Consolidated Figures in Rs. Crores / View Standalone

      Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 TTM
      553 643 966 1,665 2,306 2,590 2,757
      511 499 736 1,378 1,910 2,084 2,231
      Operating Profit 42 144 230 287 396 505 526
      OPM % 8% 22% 24% 17% 17% 20% 19%
      7 -102 -3 -21 58 79 107
      Interest 6 9 7 6 31 49 31
      Depreciation 17 19 26 33 60 76 78
      Profit before tax 26 14 195 226 363 459 524
      Tax % 45% 191% 23% 28% 27% 27%
      14 -12 149 163 266 337 384
      EPS in Rs 89.98 -40.20 951.96 937.73 11.99 15.14 16.34
      Dividend Payout % 0% 0% 0% 0% 0% 0%
      Compounded Sales Growth
      10 Years: %
      5 Years: 36%
      3 Years: 39%
      TTM: 8%
      Compounded Profit Growth
      10 Years: %
      5 Years: 88%
      3 Years: 32%
      TTM: 31%
      Stock Price CAGR
      10 Years: %
      5 Years: %
      3 Years: %
      1 Year: %
      Return on Equity
      10 Years: %
      5 Years: %
      3 Years: 29%
      Last Year: 27%

      Balance Sheet

      Consolidated Figures in Rs. Crores / View Standalone

      Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Sep 2024
      Equity Capital 0.31 0.31 0.31 0.35 44 44 48
      Reserves 73 -105 324 764 1,020 1,385 2,312
      147 483 51 66 502 490 88
      108 222 220 524 638 627 576
      Total Liabilities 329 600 596 1,353 2,204 2,546 3,024
      104 119 86 138 664 646 632
      CWIP 0 0 0 0 0 0 0
      Investments 0 13 0 120 614 796 917
      225 468 510 1,096 926 1,103 1,475
      Total Assets 329 600 596 1,353 2,204 2,546 3,024

      Cash Flows

      Consolidated Figures in Rs. Crores / View Standalone

      Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
      65 22 172 297 130 508
      -18 -16 -81 -158 -896 -326
      -21 136 -132 233 333 -66
      Net Cash Flow 25 143 -40 373 -433 115

      Ratios

      Consolidated Figures in Rs. Crores / View Standalone

      Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
      Debtor Days 60 127 108 97 102 91
      Inventory Days
      Days Payable
      Cash Conversion Cycle 60 127 108 97 102 91
      Working Capital Days 23 64 53 16 45 40
      ROCE % 37% 55% 46% 33% 29%

      Shareholding Pattern

      Numbers in percentages

      Jun 2024Sep 2024Dec 2024
      3.79% 4.82% 5.03%
      3.84% 3.17% 3.99%
      92.38% 92.01% 91.01%
      No. of Shareholders 2,03,5991,51,4401,53,789

      * The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

      Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

      Click on the line-items to see the names of individual entities.

      Documents

      Announcements

      Annual reports

      DRHP

      Concalls